PHC Holdings Corporation

2026/09/08 Updated
Market Cap: $1.1B (¥170.4B)
Stock Price: $8.73 (¥1,347)
Exchange Rate: 1 USD = ¥154.32

Stock Price Chart

2026/09/08 Updated
348.96
PER (Price Earnings Ratio)
vs Industry Avg: +339.4
1.01
PBR (Price to Book Ratio)
vs Industry Avg: -0.3
3.05%
Dividend Yield
vs Industry Avg: +0.10%

Price Trend

2026/09/08 Updated
Short-term
5-Day MA
-5.51%
Near-term
25-Day MA
-4.22%
Mid-term
75-Day MA
+14.09%
Long-term
200-Day MA
+22.57%

Price & Trading Details

2026/09/08 Updated

PRICE

Previous Close ¥1,378
Open ¥1,364
High ¥1,372
Low ¥1,342
Close ¥1,347

TRADING

Volume 162,800
Average Volume 493,884
Turnover ¥2億
Min. Purchase ¥134,700

Analyst Recommendations 7 analysts

Updated 2026/09/01
Strong Buy
1
1
Buy
1
1
Hold
5
5
Sell
0
Strong Sell
0
Target Price (Mean)
¥1,357
Hold
¥2,100
High
¥1,250
Median
¥1,000
Low
+20% vs Current Price
This information is based on market data from third-party data providers and is for reference only. Investment decisions are your own responsibility.

Earnings Calendar

Updated 2026/09/01
NOV
11
2026
Next Earnings Release
Q4 FY2026
EPS Estimate: ¥45.88
63days

Recent Earnings

Date EPS Est. EPS Actual Surprise
2026/08/05 ¥21.97 ¥50.06 +127.9%
2026/05/13 ¥15.83 ¥-1.60 -110.1%
2026/02/12 ¥13.50 ¥9.92 -26.5%
2025/11/11 ¥45.88 ¥14.13 -69.2%

Shareholder Composition

Updated 2026/09/01
65.9%
Insider Holdings
8.1%
Institutional
26.0%
Public Float
59
Institutional Holders
Insider Holdings 65.9%
Institutional 8.1%
Public Float 26.0%

Major Holders

Updated 2026/09/01
Institution Ownership Shares Change
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
0.32%
406.3K 0.00%
WisdomTree Trust-WisdomTree Japan Hedged Equity Fund
0.28%
352.0K +0.46%
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
0.20%
260.2K +11.15%
DFA INVESTMENT TRUST CO-The Japanese Small Company Series
0.12%
149.5K +32.53%
Dimensional ETF Trust-Dimensional International Small Cap Value ETF
0.12%
149.9K +16.11%
iShares Trust-iShares Core MSCI EAFE ETF
0.10%
131.7K 0.00%

Dividend History

Updated 2026/09/06
-%
Dividend Yield
¥21
Annual Dividend
-50.0%
YoY Growth
-%
Payout Ratio
Year Dividend Change
2026 ¥21 -50.0%
2025 ¥42 +7.7%
2024 ¥39 -45.8%
2023 ¥72 -2.7%
2022 ¥74 -

Financial Performance

2026/09/06 Updated

Revenue & Profit

Margins

Cash Flow

Financial Health

2022 2023 2024 2025
Income Statement
Revenue ¥340,452M ¥356,434M ¥353,900M ¥361,593M
Gross Profit ¥165,237M ¥169,132M ¥157,975M ¥166,224M
Operating Income ¥8,529M ¥20,515M ¥1,738M ¥22,952M
Pretax Income ¥10,522M ¥20,410M ¥2,215M ¥24,085M
Net Income -¥8,460M -¥3,221M -¥12,892M ¥10,484M
EPS -¥70.78 -¥25.84 -¥102.48 ¥82.58
Operating Margin 2.51% 5.76% 0.49% 6.35%
Balance Sheet
Total Assets ¥591,320M ¥561,567M ¥564,327M ¥532,482M
Total Equity ¥135,374M ¥138,008M ¥139,515M ¥141,639M
Total Liabilities ¥455,946M ¥423,559M ¥424,812M ¥390,843M
Cash ¥95,232M ¥60,933M ¥47,044M ¥39,592M
Interest-bearing Debt ¥307,936M ¥292,615M ¥285,045M ¥255,260M
Equity Ratio 22.89% 24.58% 24.72% 26.60%
D/E Ratio 2.27 2.12 2.04 1.80
Cash Flow
Operating CF ¥51,053M ¥21,376M ¥41,304M ¥41,941M
Investing CF -¥12,521M -¥17,520M -¥21,072M -¥8,473M
Financing CF -¥7,015M -¥40,832M -¥39,139M -¥39,068M
Free CF ¥39,317M ¥9,860M ¥26,674M ¥30,331M
Efficiency
ROE -6.25% -2.33% -9.24% 7.40%
ROA -1.43% -0.57% -2.28% 1.97%

Company Information

English Name PHC Holdings Corporation
Japanese Name PHCホールディングス(株)
Stock Code 6523.T (JPX)
Sector / Industry Healthcare / Medical Devices
Employees 8,647

About

PHC Holdings Corporation, together with its subsidiaries, provides healthcare digital and precision technology solutions in Japan, Europe, North America, and internationally. The company operates in three segments: Diabetes Management, Healthcare Solutions, and Diagnostics & Life Sciences. It offers precision anatomical pathology for cancer, including tissue processors, digital pathology, and histology consumables; cell growth and preservation, such as CFC-free ultra-low temperature freezers, CO2 incubators, and live cell metabolic analyzer and cell expansion bioreactor system; and diagnostic testing comprising clinical testing, diagnostic reagents, and digital diabetes management solutions. The company also provides patient record and billing solutions, which include electronic medical record systems and receipt systems, systems for pharmacies, and wellness and prevention; diabetes management technology, such as blood and continuous glucose monitoring systems; and medical device and drug delivery comprising contract development and manufacturing services, drug delivery systems, and digital health. It serves patients, healthcare professionals, and researchers. The company was formerly known as Panasonic Healthcare Holdings Co., Ltd. and changed its name to PHC Holdings Corporation in April 2018. PHC Holdings Corporation was founded in 1948 and is headquartered in Chiyoda, Japan.

Data provided by Yahoo Finance